OPKO Health, Inc.
OPK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,205 | $886 | $1,115 | $1,172 |
| - Cash | $415 | $272 | $436 | $432 |
| + Debt | $388 | $396 | $493 | $504 |
| Enterprise Value | $1,177 | $1,011 | $1,172 | $1,245 |
| Revenue | $152 | $157 | $150 | $184 |
| % Growth | -3.3% | 4.6% | -18.3% | – |
| Gross Profit | $71 | $49 | $43 | $85 |
| % Margin | 47% | 31.5% | 28.4% | 46.1% |
| EBITDA | $76 | -$69 | -$34 | $73 |
| % Margin | 49.8% | -44.1% | -23% | 39.8% |
| Net Income | $61 | -$148 | -$68 | $14 |
| % Margin | 40.4% | -94.7% | -45.1% | 7.6% |
| EPS Diluted | 0.03 | -0.22 | -0.1 | 0.02 |
| % Growth | 113.6% | -120% | -595% | – |
| Operating Cash Flow | -$35 | -$83 | -$35 | -$44 |
| Capital Expenditures | -$3 | -$3 | -$3 | -$5 |
| Free Cash Flow | -$38 | -$87 | -$38 | -$50 |